Master Framework For Relapse or Refractory Acute Myeloid Leukemia

Summary

This is an observational (non-interventional), prospective, cohort study that will collects data from patients diagnosed with relapsed or refractory acute myeloid leukemia afferent to the participanting clinical sites

Conditions

• Acute Myeloid Leukemia, in Relapse
• Acute Myeloid Leukemia Refractory

Interventions

OTHER

Registration into the STREAM platform

All patients fulfilling eligibility criteria will be registered into the STREAM platform. Baseline and follow up information will be recorded for each patient enrolled. Each patient will be followed up according to normal clinical practice up to 4 years.

Sponsors & Collaborators

• Hospital Vall d'Hebron

  collaborator OTHER

• Cyprus Institute of Neurology and Genetics

  collaborator OTHER

• European LeukemiaNet

  collaborator NETWORK

• Fundacion Para La Investigacion Hospital La Fe

  collaborator OTHER

• Ostedusche Hematology and Oncology Study Group

  collaborator UNKNOWN

• Ospedale Pediatrico Bambin Gesù

  collaborator OTHER

• Czech Lymphoma Study Group

  collaborator OTHER

• Charite University, Berlin, Germany

  collaborator OTHER

• Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

  collaborator OTHER

• University of Bologna

  collaborator OTHER

• Hannover Medical School

  collaborator OTHER

• German Society for Pediatric Oncology and Hematology GPOH gGmbH

  collaborator OTHER

• Toscana Life Sciences Sviluppo s.r.l.

  collaborator INDUSTRY

• Lithuanian University of Health Sciences

  collaborator OTHER

• Gruppo Italiano Malattie EMatologiche dell'Adulto

  collaborator OTHER

• Time.Lex

  collaborator UNKNOWN

• Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

  lead OTHER

Principal Investigators

• Giovanni Martinelli, MD, Prof · University of Bologna

Eligibility

Min Age

6 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-06-28

Primary Completion

2032-07-31

Completion

2032-07-31

Countries

• Germany
• Italy
• Lithuania
• Poland
• Romania
• Spain

Study Locations